Michigan spin-off Alertwatch gains FDA clearance to sell its patient monitoring services.
Alertwatch, a medtech spin-out of the University of Michigan, has received clearance from the US Food and Drug Administration (FDA) to begin selling its patient monitoring services to hospitals.
The start-up, which raised $1m last year for application to the FDA, displays easy-to-read data on patients during surgery. Its monitoring software draws on a range of sources to identify whether there any complications, and flashes up potential warnings and critical failures as amber and red alerts to surgeons.
Justin Adams,…
